India-UK FTA should be able to deal with public scrutiny episode artwork

EPISODE · Nov 8, 2022 · 22 MIN

India-UK FTA should be able to deal with public scrutiny

from BusinessLine Podcasts · host BusinessLine

The India-UK Free Trade Agreement is underway. According to reports, India is looking at greater market access for pharmaceutical products with the deal. However, the humanitarian group Doctors Without Borders mentioned that the India-UK FTA might hurt the supply of generic medicines globally. The group has also asked India and UK to keep Intellectual Property (IP) off the table. In this podcast, we discuss the views of pro-health groups about the India-UK Free Trade Agreement, the points of concern addressed by Doctors Without Border and others. --- Send in a voice message: https://podcasters.spotify.com/pod/show/business-line/message

Episode metadata supplied by the publisher feed · Published Nov 8, 2022

Embed this episode

NOW PLAYING

India-UK FTA should be able to deal with public scrutiny

0:00 22:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BusinessLine Podcasts?

This episode is 22 minutes long.

When was this BusinessLine Podcasts episode published?

This episode was published on November 8, 2022.

Can I download this BusinessLine Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!